Lansoprazole

Found 4 Sample Hits

m/z	Adducts	Species	Organ	Scanning	Sample
334.0614	[M+H-2H2O]+ PPM:1.9	Vitis vinifera	Fruit	MALDI (DHB)	grape_dhb_91_1 - Grape Database Resolution: 50μm, 120x114 Description Grape berries fruit, condition: Ripe
334.0613	[M+H-2H2O]+ PPM:2.2	Vitis vinifera	Fruit	MALDI (DHB)	grape_dhb_164_1 - Grape Database Resolution: 17μm, 136x122 Description Grape berries fruit, condition: Late
334.0614	[M+H-2H2O]+ PPM:1.9	Vitis vinifera	Fruit	MALDI (DHB)	grape_dhb_163_1 - Grape Database Resolution: 17μm, 132x115 Description Grape berries fruit, condition: Late
334.0615	[M+H-2H2O]+ PPM:1.6	Posidonia oceanica	root	MALDI (CHCA)	MS1_20180404_PO_1200 - MTBLS1746 Resolution: 17μm, 193x208 Description

Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. [HMDB] Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].